Priority Date: 15.06.12 (GB 20120010686)

V1B RECEPTOR ANTAGONIST FOR USE IN THE TREATMENT OF PATIENTS HAVING AN ELEVATED AVP LEVEL AND/OR AN ELEVATED COPEPTIN LEVEL

  • Application ID: EP13729363
  • Status: GRANT OF PATENT INTENDED

Attorney

operating since 1995
Headquarter in Munich and 4 offices
active in Legal Services and IP Consulting

Specialization

This EP application has the IPC class A61, C07, and G01. We found, that TransMIT GmbH, Kailuweit & Uhlemann, dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB, Kilburn & Strode LLP, Potter Clarkson LLP and 62 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 15.06.2012 - Priority Date (GB 20120010686)
  • 19.12.2013 - Publication A1 (WO2013186399)
  • 22.04.2015 - Publication A1 (EP2861253)